Search

everythinglearnresearchcommunity

for

Search:↓

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Obese women with PCOS are more likely to have fatty liver disease.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Plant extracts can benefit skin but must be safe and high-quality.

Melatonin improved mental health and metabolism in women with PCOS.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

Lower LDL-c levels predict higher COVID-19 mortality.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.